Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries

Thumbnail Image
File version
Version of Record (VoR)
Zeng, Hongmei
Chen, Wanqing
Zheng, Rongshou
Zhang, Siwei
Ji, John S
Zou, Xiaonong
Xia, Changfa
Sun, Kexin
Yang, Zhixun
Li, He
Wang, Ning
Han, Renqiang
Liu, Shuzheng
Li, Huizhang
Mu, Huijuan
He, Yutong
Xu, Yanjun
Fu, Zhentao
Zhou, Yan
Jiang, Jie
Yang, Yanlei
Chen, Jianguo
Wei, Kuangrong
Fan, Dongmei
Wang, Jian
Fu, Fangxian
Zhao, Deli
Song, Guohui
Chen, Jianshun
Jiang, Chunxiao
Zhou, Xin
Gu, Xiaoping
Jin, Feng
Li, Qilong
Li, Yanhua
Wu, Tonghao
Yan, Chunhua
Dong, Jianmei
Hua, Zhaolai
Baade, Peter
Bray, Freddie
Jemal, Ahmedin
Yu, Xue Qin
He, Jie
Griffith University Author(s)
Primary Supervisor
Other Supervisors
File type(s)

Background: From 2003 to 2005, standardised 5-year cancer survival in China was much lower than in developed countries and varied substantially by geographical area. Monitoring population-level cancer survival is crucial to the understanding of the overall effectiveness of cancer care. We therefore aimed to investigate survival statistics for people with cancer in China between 2003 and 2015.

Methods: We used population-based data from 17 cancer registries in China. Data for the study population was submitted by the end of July 31, 2016, with follow-up data on vital status obtained on Dec 31, 2015. We used anonymised, individual cancer registration records of patients (aged 0–99 years) diagnosed with primary, invasive cancers from 2003 to 2013. Patients eligible for inclusion had data for demographic characteristics, date of diagnosis, anatomical site, morphology, behaviour code, vital status, and last date of contact. We analysed 5-year relative survival by sex, age, and geographical area, for all cancers combined and 26 different cancer types, between 2003 and 2015. We stratified survival estimates by calendar period (2003–05, 2006–08, 2009–11, and 2012–15).

Findings: There were 678 842 records of patients with invasive cancer who were diagnosed between 2003 and 2013. Of these records, 659 732 (97·2%) were eligible for inclusion in the final analyses. From 2003–05 to 2012–15, age-standardised 5-year relative survival increased substantially for all cancers combined, for both male and female patients, from 30·9% (95% CI 30·6–31·2) to 40·5% (40·3–40·7). Age-standardised 5-year relative survival also increased for most cancer types, including cancers of the uterus (average change per calendar period 5·5% [95% CI 2·5–8·5]), thyroid (5·4% [3·2–7·6]), cervix (4·5% [2·9–6·2]), and bone (3·2% [2·1–4·4]). In 2012–15, age-standardised 5-year survival for all patients with cancer was higher in urban areas (46·7%, 95% CI 46·5–47·0) than in rural areas (33·6%, 33·3–33·9), except for patients with oesophageal or cervical cancer; but improvements in survival were greater for patients residing in rural areas than in urban areas. Relative survival decreased with increasing age. The increasing trends in survival were consistent with the upward trends of medical expenditure of the country during the period studied.

Interpretation: There was a marked overall increase in cancer survival from 2003 to 2015 in the population covered by these cancer registries in China, possibly reflecting advances in the quality of cancer care in these areas. The survival gap between urban and rural areas narrowed over time, although geographical differences in cancer survival remained. Insight into these trends will help prioritise areas that need increased cancer care.

Journal Title
Lancet Global Health
Conference Title
Book Title
Thesis Type
Degree Program
Publisher link
Patent number
Grant identifier(s)
Rights Statement
Rights Statement
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Access the data
Related item(s)
Clinical sciences
Health services and systems
Public health
Persistent link to this record